on Cantourage Group SE (isin : DE000A3DSV01)
Cantourage Group SE Enters Polish Cannabis Market
Cantourage Group SE, a leading European cannabis company, has initiated its first export of medical craft cannabis to Poland. The company has formed a long-term supply agreement with Polish wholesaler PharmaVitae, aiming to expand their collaboration in 2025. This move marks Cantourage's entry into Poland, a rapidly growing market for medical cannabis.
The initial product in this partnership is "Mac 1," a cannabis strain well-received in Germany and the UK. Cantourage plans to introduce more varieties to leverage opportunities in the Polish market. PharmaVitae has swiftly expanded its distribution network, now reaching over 1,200 pharmacies compared to 400 in 2023, highlighting the growing acceptance of medical cannabis in Poland.
The Polish market saw significant demand in 2023, with over 4.6 tons of medical cannabis distributed, and projections suggest robust growth in 2024. Cantourage's agility in scaling its operations meets this increasing demand, ensuring a reliable supply for PharmaVitae's expanding network.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cantourage Group SE news